What is Diagnostic Solutions?
Diagnostic Solutions operates as a specialized laboratory entity, providing critical diagnostic testing services to healthcare practitioners. The company is best known for its GI-MAP Microbial Assay Plus, a sophisticated diagnostic tool that offers granular insights into gastrointestinal health. By integrating comprehensive stool analysis and organic acids testing, the firm provides actionable data that enables personalized medicine protocols. Beyond its core testing capabilities, the organization maintains the DSL Academy, an educational platform designed to bridge the gap between complex laboratory data and clinical application, ensuring that healthcare providers can effectively translate diagnostic findings into improved patient health outcomes.
How much funding has Diagnostic Solutions raised?
Diagnostic Solutions has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Diagnostic Solutions
PPP
Public-Private Partnership
What's next for Diagnostic Solutions?
With this late-stage financing, Diagnostic Solutions is poised to scale its infrastructure and expand its diagnostic portfolio. The strategic allocation of this capital will likely focus on enhancing laboratory throughput, refining the proprietary GI-MAP technology, and broadening the reach of the DSL Academy. As the demand for precision diagnostics continues to rise, the company is strategically positioned to capture additional market share by providing clinicians with the high-resolution data necessary for evidence-based treatment plans. Future growth will likely center on technological integration and the scaling of its educational ecosystem to support a global network of practitioners.
See full Diagnostic Solutions company page
